CASI Pharmaceuticals Stock News

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) just released its latest first-quarter results and things are looking...

CASI is focused on developing and commercialising drugs for the Chinese market most notably within the field of hematology/oncology using an innovative in-licen

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shareholders will have a reason to smile today, with the analysts making...

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial resu

By Beth Senko, CFA NASDAQ:CASI READ THE FULL CASI RESEARCH REPORT CASI Pharmaceuticals (NASDAQ:CASI) signaled a shift in its business strategy in March – focusing its efforts on its hematology franc

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced that Dr. Wei-

NEW YORK, NY / ACCESSWIRE / April 6, 2020 / Solebury Trout, a boutique investor relations and corporate communications firm, announced today that it will be hosting a fourth day of presentations as pa

Market forces rained on the parade of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shareholders today, when the analysts...

Tables of the top insider purchases and sales filed with the SEC on 3/27/20, based on dollar value. Dollar values often do not equate with significance when it

Those following along with CASI Pharmaceuticals, Inc. (NASDAQ:CASI) will no doubt be intrigued by the recent purchase...